TABLE 1 WORLD ANALGESICS MARKETBASE CASE SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)
TABLE 2 WORLD ANALGESICS MARKET RAPID GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)
TABLE 3 WORLD ANALGESICS MARKET DIMINISHING GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)
TABLE 4 PORTERS FIVE FORCES ANALYSIS
TABLE 5 CLINICAL TRIALS - ANALGESICS
TABLE 6 GLOBAL INCIDENCES OF DISEASES
TABLE 7 WORLD ANALGESICS MARKET, BY TYPE, 2015-2022 ($MILLION)
TABLE 8 WORLD NON-OPIOIDS ANALGESICS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 9 WORLD OPIOID ANALGESICS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 10 WORLD ANALGESICS MARKET BY ROUTE OF ADMINISTRATION, 2015-2022 ($MILLION)
TABLE 11 WORLD ANALGESICS ORAL ROUTE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 12 WORLD ANALGESICS INTRAVENOUS ROUTE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 13 WORLD ANALGESICS RECTAL ROUTE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 14 WORLD ANALGESICS TRANSDERMAL ROUTE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 15 WORLD ANALGESICS TOPICAL ROUTE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 16 WORLD ANALGESICS MODE OF APPLICATION BY TYPE, 2015-2022 ($MILLION)
TABLE 17 WORLD ANALGESICS MODE OF APPLICATION BY TYPE, 2015-2022 ($MILLION)
TABLE 18 WORLD ANALGESICS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 19 NORTH AMERICA ANALGESICS MARKET, BY TYPE, 2015-2022 ($MILLION)
TABLE 20 NORTH AMERICA ANALGESICS MARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 21 EUROPE ANALGESICS MARKET, BY TYPES, 2015-2022 ($MILLION)
TABLE 22 EUROPE ANALGESICS MARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 23 ASIA PACIFIC ANALGESIC MARKET, BY TYPES, 2015-2022 ($MILLION)
TABLE 24 ASIA PACIFIC ANALGESIC MARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 25 LAMEA ANALGESICS MARKET, BY TYPES, 2015-2022 ($MILLION)
TABLE 26 LAMEA ANALGESICS MARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 27 COMPANY SNAPSHOT OF BAYER AG
TABLE 28 BAYER AG OPERATING SEGMENTS
TABLE 29 COMPANY SNAPSHOT OF NOVARTIS AG
TABLE 30 NOVARTIS AG OPERATINGSEGEMENTS
TABLE 31 GLAXOSMITHKLINE PLC SNAPSHOT
TABLE 32 GLAXOSMITHKLINE PLC OPERATINGSEGEMENTS
TABLE 33 COMPANY SNAPSHOT OF PFIZER INC.
TABLE 34 PFIZER INC. OPERATING SEGMENTS
TABLE 35 COMPANY SNAPSHOT OF JOHNSON &JOHSNON
TABLE 36 JOHNSON &JOHSNON OPERATING SEGMENTS
TABLE 37 COMPANY SNAPSHOT OF RB
TABLE 38 RECKITT BENCKISER OPERATING SEGMENTS
TABLE 39 COMPANY SNAPSHOT OF ENDO PHARMACEUTICALS
TABLE 40 ENDO PHARMACEUTICALS OPERATING SEGMENTS
TABLE 41 COMPANY SNAPSHOT OF BRISTOL-MYERS SQUIBB
TABLE 42 COMPANY SNAPSHOT OF ELI LILY AND COMPANY
TABLE 43 ELI LILY OPERATING SEGMENTS
TABLE 44 COMPANY SNAPSHOT OF SANOFI
TABLE 45 SANOFI OPERATING SEGMENTS
LIST OF FIGURE
FIG. 1 TOP IMPACTING FACTORS, BASE CASE SCENARIO (2022-2027)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2022-2027)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2022-2027)
FIG. 4 TOP INVESTMENT POCKETS OF ANALGESICS MARKET BY ROUTE OF ADMINISTRATION, 2015-2022
FIG. 5 TOP WINNING STRATEGIES
FIG. 6 TOP FACTORS IMPACTING WORLD ANALGESICS MARKET, 2015-2022
FIG. 7 DRUG POISONING DEATHS INVOLVING OPIOID ANALGESICS
FIG. 8 LEADING INTERNAL ANALGESIC TABLET BRANDS, 2015, BASED ON SALES ($MILLION)
FIG. 9 UNITED STATES ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 10 CANADA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 11 MEXICO ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 12 UNITED KINGDOM ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 13 GERMANY KINGDOM ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 14 SPAIN KINGDOM ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 15 SWEDEN ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 16 FRANCE ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 17 RUSSIA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 18 DENMARK ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 19 REST OF EUROPE ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 20 JAPAN ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 21 CHINA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 22 INDIA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 23 AUSTRALIA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 24 INDONESIA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 25 REST OF ASIA-PACIFIC ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 26 BRAZIL ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 27 VENEZUELA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 28 CHILE ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 29 SAUDI ARABIA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 30 UAE ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 31 MOROCCO ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 32 KENYA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 33 NIGERIA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 34 LAMEA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 35 REVENUE GENERATED BY BAYER AG (2012-2014)
FIG. 36 BAYER AG, %REVENUE, BY BUSINESS SEGMENTS, (2014)
FIG. 37 BAYER AG, % REVENUE, BY GEOGRAPHY (2014)
FIG. 38 SWOT ANALYSIS OF BAYER AG
FIG. 39 REVENUE GENERATED BY NOVARTIS AG (2012-2014)
FIG. 40 NOVARTIS AG, % REVENUE BY BUSINESS SEGMENTS (2014)
FIG. 41 NOVARTIS AG. % REVENUE BY GEOGRAPHY (2014)
FIG. 42 SWOT ANALYSIS OF NOVARTIS AG
FIG. 43 REVENUE GENERATED BY GLAXOSMITHKLINE PLC (2012-2014)
FIG. 44 GLAXOSMITHKLINE PLC, % REVENUE BY BUSINESS SEGMENTS (2014)
FIG. 45 GLAXOSMITHKLINE PLC, % REVENUE BY GEOGRAPHY (2014)
FIG. 46 SWOT ANALYSIS OF GLAXOSMITHKLINE PLC
FIG. 47 REVENUE GENERATED BY PFIZER INC. (2012-2014)
FIG. 48 PFIZER INC., %REVENUE, BY BUSINESS SEGMENTS, (2014)
FIG. 49 PFIZER INC., % REVENUE, BY GEOGRAPHY (2014)
FIG. 50 SWOT ANALYSIS OF PFIZER INC.
FIG. 51 REVENUE GENERATED BY JOHNSON & JOHNSON (2012-2014)
FIG. 52 JOHNSON & JOHNSON, %REVENUE, BY BUSINESS SEGMENTS, (2014)
FIG. 53 JOHNSON & JOHNSON, % REVENUE, BY GEOGRAPHY (2014)
FIG. 54 SWOT ANALYSIS OF JOHNSON &JOHSNON
FIG. 55 REVENUE GENERATED BY RECKITT BENCKISER (2012-2014)
FIG. 56 RECKITT BENCKISER, % REVENUE, BY BUSINESS SEGMENTS, (2014)
FIG. 57 RECKITT BENCKISER, % REVENUE, BY GEOGRAPHY (2014)
FIG. 58 SWOT ANALYSIS OF RECKITT BENCKISER
FIG. 59 REVENUE GENERATED BY ENDO PHARMACEUTICALS (2012-2014)
FIG. 60 ENDO PHARMACEUTICALS, % REVENUE, BY BUSINESS SEGMENTS, (2014)
FIG. 61 SWOT ANALYSIS OF ENDO PHARMACEUTICALS
FIG. 62 REVENUE GENERATED BY BRISTOL-MYERS SQUIBB (2012-2014)
FIG. 63 BRISTOL-MYERS SQUIBB, % REVENUE, BY GEOGRAPHY (2014)
FIG. 64 SWOT ANALYSIS OF BRISTOL-MYERS SQUIBB
FIG. 65 REVENUE GENERATED BY ELI LILY (2012-2014)
FIG. 66 ELI LILY, %REVENUE, BY BUSINESS SEGMENTS, (2014)
FIG. 67 ELI LILY, % REVENUE, BY GEOGRAPHY (2014)
FIG. 68 SWOT ANALYSIS OF ELI LILY
FIG. 69 REVENUE GENERATED BY SANOFI (2012-2014)
FIG. 70 SANOFI, %REVENUE, BY BUSINESS SEGMENTS, (2014)
FIG. 71 SANOFI, %REVENUE, BY GEOGRAPHY (2014)
FIG. 72 SWOT ANALYSIS OF SANOFI